Latest filing published 05 Jul 2018 for Kezar Life Sciences, Inc..
Insider track record
No signal scores available.
Thomas F. Steyer: trading record in brief
Thomas F. Steyer discloses dealings in 2 companies, chiefly Kezar Life Sciences, Inc. and Capitalsource Inc. In total, 3 filings cover trades dated from 1 May 2008 to 25 June 2018.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 July 2018 came the latest disclosure, a transaction in Kezar Life Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 10 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas F. Steyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 210,326 sharesCommon StockSEC:0000872574-18-000003:0
- 125,927 sharesCommon StockSEC:0000872574-18-000003:1
- 12,376 sharesCommon StockSEC:0001182489-08-000496:0
3 of 3 declarations